|
1
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalish ED, Iida N, Moffat FL and
Bourguignon LY: A new CD44V3-containing isoform is involved in
tumor cell growth and migration during human breast carcinoma
progression. Front Biosci. 4:A1–A8. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma F, Li H, Wang H, Shi X, Fan Y, Ding X,
Lin C, Zhan Q, Qian H and Xu B: Enriched
CD44+/CD24− population drives the aggressive
phenotypes presented in triple-negative breast cancer (TNBC).
Cancer Lett. 353:153–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hurt EM, Kawasaki BT, Klarmann GJ, Thomas
SB and Farrar WL: CD44+CD24− prostate cells
are early cancer progenitor/stem cells that provide a model for
patients with poor prognosis. Br J Cancer. 98:756–765. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petersen PE: Oral cancer prevention and
control - the approach of the World Health Organization. Oral
Oncol. 45:454–460. 2009. View Article : Google Scholar
|
|
9
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
10
|
Kim CF, Jackson EL, Woolfenden AE,
Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen C, Wei Y, Hummel M, Hoffmann TK,
Gross M, Kaufmann AM and Albers AE: Evidence for
epithelial-mesenchymal transition in cancer stem cells of head and
neck squamous cell carcinoma. PLoS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang SJ, Wong G, de Heer AM, Xia W and
Bourguignon LY: CD44 variant isoforms in head and neck squamous
cell carcinoma progression. Laryngoscope. 119:1518–1530. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bourguignon LY, Wong G, Earle C and Chen
L: Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes
miR-302 expression leading to self-renewal, clonal formation, and
cisplatin resistance in cancer stem cells from head and neck
squamous cell carcinoma. J Biol Chem. 287:32800–32824. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pirruccello SJ and LeBien TW: The human B
cell-associated antigen CD24 is a single chain sialoglycoprotein. J
Immunol. 136:3779–3784. 1986.PubMed/NCBI
|
|
18
|
Fischer GF, Majdic O, Gadd S and Knapp W:
Signal transduction in lymphocytic and myeloid cells via CD24, a
new member of phosphoinositol-anchored membrane molecules. J
Immunol. 144:638–641. 1990.PubMed/NCBI
|
|
19
|
Sano A, Kato H, Sakurai S, Sakai M, Tanaka
N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, et al: CD24
expression is a novel prognostic factor in esophageal squamous cell
carcinoma. Ann Surg Oncol. 16:506–514. 2009. View Article : Google Scholar
|
|
20
|
Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu
SJ, Shi YH, Wang XY, Dai Z, Shi GM, et al: CD24 is a novel
predictor for poor prognosis of hepatocellular carcinoma after
surgery. Clin Cancer Res. 15:5518–5527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yeung TM, Gandhi SC, Wilding JL, Muschel R
and Bodmer WF: Cancer stem cells from colorectal cancer-derived
cell lines. Proc Natl Acad Sci USA. 107:3722–3727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen YC, Chen YW, Hsu HS, Tseng LM, Huang
PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chiu CC, Lee LY, Li YC, Chen YJ, Lu YC, Li
YL, Wang HM, Chang JT and Cheng AJ: Grp78 as a therapeutic target
for refractory head-neck cancer with
CD24−CD44+ stemness phenotype. Cancer Gene
Ther. 20:606–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hisaka T, Yano H, Ogasawara S, Momosaki S,
Nishida N, Takemoto Y, Kojiro S, Katafuchi Y and Kojiro M:
Interferon-alphaCon1 suppresses proliferation of liver cancer cell
lines in vitro and in vivo. J Hepatol. 41:782–789. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamamoto E, Kohama G, Sunakawa H, Iwai M
and Hiratsuka H: Mode of invasion, bleomycin sensitivity, and
clinical course in squamous cell carcinoma of the oral cavity.
Cancer. 51:2175–2180. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rizzo S, Hersey JM, Mellor P, Dai W,
Santos-Silva A, Liber D, Luk L, Titley I, Carden CP, Box G, et al:
Ovarian cancer stem cell-like side populations are enriched
following chemotherapy and overexpress EZH2. Mol Cancer Ther.
10:325–335. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
‘side population’ of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004.
View Article : Google Scholar
|
|
28
|
Yajima T, Ochiai H, Uchiyama T, Takano N,
Shibahara T and Azuma T: Resistance to cytotoxic
chemotherapy-induced apoptosis in side population cells of human
oral squamous cell carcinoma cell line Ho-1-N-1. Int J Oncol.
35:273–280. 2009.PubMed/NCBI
|
|
29
|
Yang Z, Liu Y, Liao J, Gong C, Sun C, Zhou
X, Wei X, Zhang T, Gao Q, Ma D, et al: Quercetin induces
endoplasmic reticulum stress to enhance cDDP cytotoxicity in
ovarian cancer: Involvement of STAT3 signaling. FEBS J.
282:1111–1125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karaayvaz M, Zhai H and Ju J: miR-129
promotes apoptosis and enhances chemosensitivity to 5-fluorouracil
in colorectal cancer. Cell Death Dis. 4:e6592013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Longley DB, Wilson TR, McEwan M, Allen WL,
McDermott U, Galligan L and Johnston PG: c-FLIP inhibits
chemotherapy-induced colorectal cancer cell death. Oncogene.
25:838–848. 2006. View Article : Google Scholar
|
|
32
|
Micheau O, Solary E, Hammann A and
Dimanche-Boitrel MT: Fas ligand-independent, FADD-mediated
activation of the Fas death pathway by anticancer drugs. J Biol
Chem. 274:7987–7992. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Murakami S, Ninomiya W, Sakamoto E,
Shibata T, Akiyama H and Tashiro F: SRY and OCT4 are required for
the acquisition of cancer stem cell-like properties and are
potential differentiation therapy targets. Stem Cells.
33:2652–2663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Oliveira LR, Oliveira-Costa JP, Araujo IM,
Soave DF, Zanetti JS, Soares FA, Zucoloto S and Ribeiro-Silva A:
Cancer stem cell immunophenotypes in oral squamous cell carcinoma.
J Oral Pathol Med. 40:135–142. 2011. View Article : Google Scholar
|
|
35
|
Abdulmajeed AA, Dalley AJ and Farah CS:
Putative cancer stem cell marker expression in oral epithelial
dysplasia and squamous cell carcinoma. J Oral Pathol Med.
42:755–760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bánkfalvi A, Krassort M, Buchwalow IB,
Végh A, Felszeghy E and Piffkó J: Gains and losses of adhesion
molecules (CD44, E-cadherin, and beta-catenin) during oral
carcinogenesis and tumour progression. J Pathol. 198:343–351. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi D, Lee HW, Hur KY, Kim JJ, Park GS,
Jang SH, Song YS, Jang KS and Paik SS: Cancer stem cell markers
CD133 and CD24 correlate with invasiveness and differentiation in
colorectal adenocarcinoma. World J Gastroenterol. 15:2258–2264.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kristiansen G, Denkert C, Schlüns K, Dahl
E, Pilarsky C and Hauptmann S: CD24 is expressed in ovarian cancer
and is a new independent prognostic marker of patient survival. Am
J Pathol. 161:1215–1221. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bircan S, Kapucuoglu N, Baspinar S, Inan G
and Candir O: CD24 expression in ductal carcinoma in situ and
invasive ductal carcinoma of breast: An immunohistochemistry-based
pilot study. Pathol Res Pract. 202:569–576. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Darwish NS, Kim MA, Chang MS, Lee HS, Lee
BL, Kim YI and Kim WH: Prognostic significance of CD24 expression
in gastric carcinoma. Cancer Res Treat. 36:298–302. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Herold-Mende C, Seiter S, Born AI, Patzelt
E, Schupp M, Zöller J, Bosch FX and Zöller M: Expression of CD44
splice variants in squamous epithelia and squamous cell carcinomas
of the head and neck. J Pathol. 179:66–73. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fonseca I, Pereira T, Rosa-Santos J and
Soares J: Expression of CD44 isoforms in squamous cell carcinoma of
the border of the tongue: A correlation with histological grade,
pattern of stromal invasion, and cell differentiation. J Surg
Oncol. 76:115–120. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Masuda M, Kuratomi Y, Shiratsuchi H,
Nakashima T, Naonobu K and Komiyama S: Decreased CD44H expression
in early-stage tongue carcinoma associates with late nodal
metastases following interstitial brachytherapy. Head Neck.
22:662–665. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Williams HK, Sanders DS, Jankowski JA,
Landini G and Brown AM: Expression of cadherins and catenins in
oral epithelial dysplasia and squamous cell carcinoma. J Oral
Pathol Med. 27:308–317. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bànkfalvi A and Piffkò J: Prognostic and
predictive factors in oral cancer: The role of the invasive tumour
front. J Oral Pathol Med. 29:291–298. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sagiv E, Memeo L, Karin A, Kazanov D,
Jacob-Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H and Arber N:
CD24 is a new oncogene, early at the multistep process of
colorectal cancer carcinogenesis. Gastroenterology. 131:630–639.
2006. View Article : Google Scholar : PubMed/NCBI
|
